Haw ParHAWPF 96 PB Ratio is 0.80 as of Jun. 29, 2026, which is at its 10-year median of 0.80. GuruFocus rates HAWPF with a GF Score™ of 96/100 and a GF Value™ of $8.94. The stock has 3 warning signs investors should review. Among 922 Drug Manufacturers companies, Haw Par ranks better than 81.56% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-29), Haw Par's share price is $12.00. Haw Par's Book Value per Share for the quarter that ended in Dec. 2025 was $15.02. Hence, Haw Par's PB Ratio of today is 0.80.
The historical rank and industry rank for Haw Par's PB Ratio or its related term are showing as below:
HAWPF'
s PB Ratio Range Over the Past 10 Years
Min: 0.57 Med: 0.8 Max: 1.17
Current: 0.82
During the past 13 years, Haw Par's highest PB Ratio was 1.17. The lowest was 0.57. And the median was 0.80.
HAWPF's PB Ratio is ranked better than 81.56% of 922
companies
in the Drug Manufacturers industry
Industry Median: 1.845
vs HAWPF: 0.82
During the past 12 months, Haw Par's average Book Value Per Share Growth Rate was 3.40% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 6.50% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 8.10% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 5.20% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Haw Par was 47.90% per year. The lowest was -2.30% per year. And the median was 5.15% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Haw Par PB Ratio Related Terms
Haw Par PB Ratio Historical Data
* Premium members only.
The historical data trend for Haw Par's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - General subindustry, Haw Par's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Haw Par PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Haw Par's PB Ratio distribution charts can be found below:
* The bar in red indicates where Haw Par's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Haw Par's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Haw Par (HAWPF) has a PB Ratio of 0.80 as of Jun. 29, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Haw Par and its competitors. This is near median its historical median of 0.80. Over the past decade, Haw Par's PB Ratio has ranged from 0.57 to 1.17. According to the industry distribution chart, Haw Par ranks #170 out of 922 companies in the Drug Manufacturers industry, placing it in the top 18.4%.
Is Haw Par's PB Ratio too high?
Haw Par's current PB Ratio of 0.80 is near median its 10-year median of 0.80. Over the past 10 years, this metric has ranged from a low of 0.57 to a high of 1.17. The Drug Manufacturers industry median PB Ratio is 1.85. Haw Par's value of 0.80 is 56.6% below this industry median. Based on the distribution chart, Haw Par ranks #170 out of 922 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Haw Par has a GF Score™ of 96/100, reflecting its overall financial health beyond just this single metric.
How does Haw Par's PB Ratio compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Haw Par ranks #170 out of 922 companies for PB Ratio. This places Haw Par in the top 18% of its industry — outperforming the majority of peers. The industry median PB Ratio is 1.85. Haw Par's value of 0.80 is 56.6% below this benchmark. Historically, Haw Par's own PB Ratio has ranged from 0.57 to 1.17 over the past decade. While the company's 10-year median is 0.80 vs. the industry median of 1.85, Haw Par has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.85, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Haw Par's current PB Ratio of 0.80 is 56.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Haw Par and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Haw Par's current PB Ratio is 0.80, which is near median its own 10-year median of 0.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Haw Par stock overvalued right now?
Haw Par (HAWPF) has a current PB Ratio of 0.80. The stock's GF Value™ is $8.94, compared to a current price of $12.00 — trading 34.2% above its estimated fair value. The current PB Ratio is 0.80, which is near median its 10-year median of 0.80 and 56.6% below the Drug Manufacturers industry median of 1.85. Haw Par's overall GF Score™ is 96/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Haw Par (HAWPF), the current PB Ratio is 0.80 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Haw Par (HAWPF) Overvalued in 2026?
Based on GuruFocus' analysis, Haw Par stock appears to be overvalued.
The current stock price of $12.00 is trading 34.2% above its estimated GF Value™ of $8.94.
Key valuation signals for HAWPF:
PB Ratio: 0.80 (near median its 10-year median of 0.80)
GF Value™: $8.94 vs. price of $12.00 (34.2% above fair value)
Industry Position: 56.6% below the Drug Manufacturers median (#170 of 922)
No single metric tells the full story. See the HAWPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Haw Par Corp Ltd is a drug manufacturing company that operates multiple brands. The company is to expand its core businesses through product brand extension, strategic alliances, and exploring potential acquisitions. Its operating segments include the Healthcare segment, Investments segment, Property segment, and Leisure segment. The company generates the majority of its revenue from the Healthcare segment. Its Healthcare segment manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brands. Geographically, it generates key revenue from the other ASEAN and other Asian countries.
96GF Score
Get the complete analysis for HAWPF
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HAWPF has been successfully added to your 
